We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Time intervals in the pathway to emergency cancer diagnosis

    Xavier Bosch

    *Author for correspondence:

    E-mail Address: xavbosch@clinic.cat

    Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & Clínic Foundation for Biomedical Research (FCRB), University of Barcelona, Barcelona, 08036, Spain

    ,
    Elisabet Montori-Palacin

    Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & Clínic Foundation for Biomedical Research (FCRB), University of Barcelona, Barcelona, 08036, Spain

    ,
    José Naval-Álvarez

    Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & Clínic Foundation for Biomedical Research (FCRB), University of Barcelona, Barcelona, 08036, Spain

    ,
    Ana Matas

    Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & Clínic Foundation for Biomedical Research (FCRB), University of Barcelona, Barcelona, 08036, Spain

    ,
    Pedro Moreno

    Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & Clínic Foundation for Biomedical Research (FCRB), University of Barcelona, Barcelona, 08036, Spain

    &
    Alfonso López-Soto

    Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & Clínic Foundation for Biomedical Research (FCRB), University of Barcelona, Barcelona, 08036, Spain

    Published Online:https://doi.org/10.2217/fon-2023-0062

    Aim: Evidence on time-based metrics for cancers diagnosed through emergency presentation is lacking. We examined the duration of intervals from first symptoms to cancer diagnosis in the emergency versus primary care (PC) presentation route. Methods: Retrospective study of outpatients diagnosed with 15 solid cancers over 5 years. The outcome was the length of prediagnostic intervals by diagnostic route. Results: Median intervals in emergency presenters (n = 3167) were shorter than in PC presenters (n = 2215). However, intervals in emergency presenters with three or more prior PC consultations were similar to PC but remarkably longer than in those with one or two and no consultations. Conclusion: As we provide new interval measures for the emergency diagnostic pathway, results highlight the contribution of prior consultations to interval lengths.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. McPhail S, Swann R, Johnson SA et al. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncol. 23(5), 587–600 (2022). •• To date, one of the most relevant papers on emergency diagnosis of cancer. Provides a uniform definition of emergency presentation across different international jurisdictions in six high-income countries and examines the risk of emergency presentation and short-term mortality.
    • 2. Zhou Y, Abel GA, Hamilton W et al. Diagnosis of cancer as an emergency: a critical review of current evidence. Nat. Rev. Clin. Oncol. 14(1), 45–56 (2017). • A comprehensive review of the reported evidence on diagnosis of cancer as an emergency including time trends, tumor, patient and healthcare system factors.
    • 3. Neal RD, Tharmanathan P, France B et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br. J. Cancer 112(Suppl. 1), S92–S107 (2015).
    • 4. Tørring ML, Falborg AZ, Jensen H et al. Advanced-stage cancer and time to diagnosis: an International Cancer Benchmarking Partnership (ICBP) cross-sectional study. Eur. J. Cancer Care (Engl.) 28(5), e13100 (2019).
    • 5. Lyratzopoulos G. Markers and measures of timeliness of cancer diagnosis after symptom onset: a conceptual framework and its implications. Cancer Epidemiol. 38(3), 211–213 (2014).
    • 6. Mitchell E, Macdonald S, Campbell NC, Weller D, Macleod U. Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review. Br. J. Cancer 98(1), 60–70 (2008).
    • 7. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Hamilton W, Vedsted P. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br. J. Cancer 104(6), 934–940 (2011). Erratum in: Br. J. Cancer. 104(12), 1930 (2011).
    • 8. Weller D, Vedsted P, Rubin G et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br. J. Cancer 106(7), 1262–1267 (2012). •• The first study defining the key time points and intervals from symptom onset until start of treatment for cancers diagnosed following patient presentation with symptoms.
    • 9. Tørring ML, Murchie P, Hamilton W et al. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. Br. J. Cancer 117(6), 888–897 (2017).
    • 10. Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 13(4), 353–365 (2012).
    • 11. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br. J. Cancer 108(3), 686–690 (2013).
    • 12. Herbert A, Abel GA, Winters S, McPhail S, Elliss-Brookes L, Lyratzopoulos G. Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to Diagnosis data, 2006–2015. Br. J. Gen. Pract. 69(687), e724–e730 (2019).
    • 13. Lyratzopoulos G, Saunders CL, Abel GA. Are emergency diagnoses of cancer avoidable? A proposed taxonomy to motivate study design and support service improvement. Future Oncol. 10(8), 1329–1333 (2014). • Offers a vision of the mechanisms and scenarios leading to an emergency cancer diagnosis taking into account the type, severity and awareness of presenting symptom, and whether symptoms prompted patients to seek medical help or whether patients self-referred to the emergency department.
    • 14. Abel GA, Mendonca SC, McPhail S, Zhou Y, Elliss-Brookes L, Lyratzopoulos G. Emergency diagnosis of cancer and previous general practice consultations: insights from linked patient survey data. Br. J. Gen. Pract. 67(659), e377–e387 (2017). •• Provides the basis for the methodology of this study.
    • 15. Murchie P, Smith SM, Yule MS et al. Does emergency presentation of cancer represent poor performance in primary care? Insights from a novel analysis of linked primary and secondary care data. Br. J. Cancer 116(9), 1148–1158 (2017). • Explores the nature and content of the clinical interactions between patients and primary care physicians before being referred to hospital as an emergency.
    • 16. Pearson C, Fraser J, Peake M et al. Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer. Cancer Epidemiol. 61, 111–118 (2019).
    • 17. Bosch X, Jordán A, López-Soto A. Quick diagnosis units: avoiding referrals from primary care to the ED and hospitalizations. Am. J. Emerg. Med. 31(1), 114–123 (2013).
    • 18. Bosch X, Escoda O, Nicolás D et al. Primary care referrals of patients with potentially serious diseases to the emergency department or a quick diagnosis unit: a cross-sectional retrospective study. BMC Fam. Pract. 15, 75 (2014).
    • 19. Bosch X, Montori-Palacin E, Martínez-Ferrer R, Aldea A, Moreno P, López-Soto A. Time intervals in the care pathway to cancer diagnosis during the COVID-19 pandemic: a large retrospective study from a high-volume center. Int. J. Cancer 152(3), 384–395 (2023).
    • 20. Bosch X, Aibar J, Capell S, Coca A, López-Soto A. Quick diagnosis units: a potentially useful alternative to conventional hospitalisation. Med. J. Aust. 191(9), 496–498 (2009).
    • 21. Spanish Health Ministry. [Estrategia en Cáncer del Sistema Nacional de Salud (Actualización 2021)]. Spanish Cancer Strategy (2021 Update) (2021). www.sanidad.gob.es/organizacion/sns/planCalidadSNS/pdf/Estrategia_en_cancer_del_Sistema_Nacional_de_Salud_Actualizacion_2021.pdf (Accessed 18 March 2023).
    • 22. TNM Classification of Malignant Tumours (8th Edition). Brierley JDGospodarowicz MKWittekind C (Eds). Wiley-Blackwell, Chichester, UK (2017).
    • 23. Monterde D, Vela E, Clèries M, Garcia-Eroles L, Roca J, Pérez-Sust P. Multimorbidity as a predictor of health service utilization in primary care: a registry-based study of the Catalan population. BMC Fam. Pract. 21(1), 39 (2020).
    • 24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40(5), 373–383 (1987).
    • 25. Hodges JL, Lehmann EL. Estimates of location based on rank tests. Ann. Math. Stat. 34, 598–611 (1963).
    • 26. Bosso L, Espejo T, Taffé P et al. Analgesic and anxiolytic effects of virtual reality during minor procedures in an emergency department. A randomized controlled study. Ann. Emerg. Med. 81(1), 84–94 (2023).
    • 27. National Cancer Registration and Analysis Service. Emergency Presentation Routes 2006–2016. www.cancerdata.nhs.uk/routestodiagnosis/emergency (Accessed 18 March 2023).
    • 28. Coxon D, Campbell C, Walter FM et al. The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments. BMC Health Serv. Res. 18(1), 677 (2018).
    • 29. Swann R, McPhail S, Witt J et al. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. Br. J. Gen. Pract. 68(666), e63–e72 (2018).
    • 30. National Cancer Registration and Analysis Service. Routes to Diagnosis 2006–2016. www.cancerdata.nhs.uk/routestodiagnosis/index (Accessed 18 March 2023).
    • 31. Public Health England. Be Clear on Cancer Evaluation. www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/be_clear_on_cancer/ (Accessed 18 March 2023).
    • 32. Keeble S, Abel GA, Saunders CL et al. Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a National Audit of Cancer Diagnosis in Primary Care. Int. J. Cancer 135(5), 1220–1228 (2014).
    • 33. Koo MM, Unger-Saldaña K, Mwaka AD et al. Conceptual framework to guide early diagnosis programs for symptomatic cancer as part of global cancer control. JCO Glob. Oncol. 7, 35–45 (2021).
    • 34. Lyratzopoulos G, Saunders CL, Abel GA et al. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br. J. Cancer 112(Suppl. 1), S35–S40 (2015).
    • 35. Mendonca SC, Abel GA, Saunders CL, Wardle J, Lyratzopoulos G. Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English Cancer Patient Experience Survey. Eur. J. Cancer Care (Engl.) 25(3), 478–490 (2016).
    • 36. Lyratzopoulos G, Wardle J, Rubin G. Rethinking diagnostic delay in cancer: how difficult is the diagnosis? BMJ 349, g7400 (2014).
    • 37. Koo MM, Hamilton W, Walter FM, Rubin GP, Lyratzopoulos G. Symptom signatures and diagnostic timeliness in cancer patients: a review of current evidence. Neoplasia 20(2), 165–174 (2018). • Provides the basis for understanding and interpreting the nature and frequency of presenting symptoms in our cancer patients.
    • 38. López-Casasnovas G, Francesc-López Seguí F, Arasanz-Goset A. Sustainability and Resilience in the Spanish Health System. The Partnership for Health System Sustainability and Resilience (PHSSR). London School of Economics and Political Science, London, UK (2021). www3.weforum.org/docs/WEF_PHSSR_Spain_Report.pdf (Accessed 18 March 2023).
    • 39. Corbella X, Barreto V, Bassetti S et al. Hospital ambulatory medicine: a leading strategy for internal medicine in Europe. Eur. J. Intern. Med. 54, 17–20 (2018).